Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study

Last updated: January 24, 2020
Sponsor: Beijing Tsinghua Chang Gung Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Biliary Tract Cancer

Digestive System Neoplasms

Liver Cancer

Treatment

N/A

Clinical Study ID

NCT04243057
RWS-BTCH-001
  • Ages > 18
  • All Genders

Study Summary

This is a multicenter, two-way, non-intervention study. the main purpose: Understand the current status of diagnosis and treatment of cholangiocarcinoma patients in China and observe the effect of different treatment options on patient recurrence and long-term survival

Secondary purpose:

  1. Exploring the actual clinical treatment situation and its compliance with the existing diagnosis and treatment of bile duct cancer

  2. Exploring the establishment of clinical research standard fields and standards for diagnosis and treatment of bile duct cancer

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. above the age of 18 years old, male or female

  2. clinical diagnosis of patients with cholangiocarcinoma

  3. Child-Pugh classification of A, B

  4. Eastern Cooperative Oncology Group scoring system (ECOG) score of 0-2 points

Exclusion

Exclusion Criteria:

  • None

Study Design

Total Participants: 5000
Study Start date:
August 30, 2019
Estimated Completion Date:
September 30, 2022

Connect with a study center

  • Beijing Tsinghua Changgung Hospital

    Beijing, Beijing 102218
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.